Literature DB >> 21495251

A comparison of the feasibility and safety of nerve-sparing radical hysterectomy with the conventional radical hysterectomy.

Elizabeth E Espino-Strebel1, Jericho Thaddeus P Luna, Efren J Domingo.   

Abstract

BACKGROUND: Radical hysterectomy has been the treatment of choice for early-stage cervical cancer. Since its introduction in oncology, modifications to the original technique were made to enhance feasibility, improve cure rate, and decrease postoperative complications. Among these are the identification and preservation of pelvic autonomic nerves, known as the nerve-sparing radical hysterectomy (RH). This retrospective study was conducted to compare the nerve-sparing with the conventional RH in terms of feasibility and safety, including bladder dysfunction and perioperative and postoperative complications and morbidities.
METHODS: Patients with biopsy-proven early-stage cervical carcinoma, cervical carcinoma with central tumor recurrence or persistence after primary radiotherapy, and endometrial carcinoma with cervical involvement treated with RH with or without nerve-sparing technique were included. The perioperative and postoperative complications and bladder function of these patients were analyzed.
RESULTS: Ninety-seven patients with early-stage cervical cancer and 24 patients with clinical stage II endometrial cancer underwent RH with or without nerve-sparing technique in a nonrandomized fashion. There was no statistically significant difference between the 2 procedures in terms of duration of surgery, intraoperative blood loss, duration of hospitalization, and morbidity. Patients who underwent the nerve-sparing approach had a statistically significant earlier return of bladder function, with a mean of 9.4 days for the cervical cancer cases (vs 21 days in the non-nerve-sparing group) and a mean of 8.5 days for the endometrial cancer cases (vs 22.6 days in the non-nerve-sparing group).
CONCLUSIONS: The technique of sparing the pelvic autonomic nerves during RH for early-stage cervical cancer and clinical stage II endometrial cancer is comparable to the conventional method in terms of perioperative complications and morbidity, but is more favorable in terms of return of bladder function.

Entities:  

Mesh:

Year:  2010        PMID: 21495251     DOI: 10.1111/igc.0b013e3181f165f2

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery.

Authors:  Fabio Castiglione; Alice Bergamini; Arianna Bettiga; Trinity J Bivalacqua; Fabio Benigni; Frank Strittmatter; Giorgio Gandaglia; Patrizio Rigatti; Francesco Montorsi; Petter Hedlund
Journal:  Eur Urol       Date:  2012-04-19       Impact factor: 20.096

2.  Conventional versus nerve-sparing radical surgery for cervical cancer: a meta-analysis.

Authors:  Hee Seung Kim; Keewon Kim; Seung Bum Ryoo; Joung Hwa Seo; Sang Youn Kim; Ji Won Park; Min A Kim; Kyoung Sup Hong; Chang Wook Jeong; Yong Sang Song
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

3.  Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer.

Authors:  Antonino Ditto; Giorgio Bogani; Umberto Leone Roberti Maggiore; Fabio Martinelli; Valentina Chiappa; Carlos Lopez; Stefania Perotto; Domenica Lorusso; Francesco Raspagliesi
Journal:  J Gynecol Oncol       Date:  2018-02-28       Impact factor: 4.401

4.  Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis.

Authors:  Emma R Allanson; Aime Powell; Max Bulsara; Hong Lim Lee; Lynette Denny; Yee Leung; Paul Cohen
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

Review 5.  Voiding dysfunction in women: How to manage it correctly.

Authors:  A Abdel Raheem; Helmut Madersbacher
Journal:  Arab J Urol       Date:  2013-08-29

6.  Classical radical hysterectomy and nerve-sparing radical hysterectomy in the treatment of cervical cancer.

Authors:  Marcin Makowski; Marek Nowak; Marian Szpakowski; Jacek Władziński; Anna Serwach-Nowińska; Łukasz Janas; Jacek R Wilczyński
Journal:  Prz Menopauzalny       Date:  2014-06-30

Review 7.  Clinical efficacy and safety of nerve-sparing radical hysterectomy for cervical cancer: a systematic review and meta-analysis.

Authors:  Ying Long; De-Sheng Yao; Xin-Wei Pan; Ting-Yu Ou
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 8.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04

9.  Predicting factors for resumption of spontaneous voiding following nerve-sparing radical hysterectomy.

Authors:  Chalaithorn Nantasupha; Kittipat Charoenkwan
Journal:  J Gynecol Oncol       Date:  2018-04-23       Impact factor: 4.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.